Back to Search
Start Over
The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas
- Source :
- BMC Cancer, BMC Cancer, Vol 19, Iss 1, Pp 1-15 (2019)
- Publication Year :
- 2018
-
Abstract
- Background S100A8 and S100A9, two heterodimer-forming members of the S100 family, aberrantly express in a variety of cancer types. However, little is known about the mechanism that regulates S100A8/S100A9 co-expression in cancer cells. Methods The expression level of S100A8/S100A9 measured in three squamous cell carcinomas (SCC) cell lines and their corresponding xenografts, as well as in 257 SCC tissues. The correlation between S100A8/S100A9, Hippo pathway and F-actin cytoskeleton were evaluated using western blot, qPCR, ChIP and Immunofluorescence staining tests. IncuCyte ZOOM long time live cell image monitoring system, qPCR and Flow Cytometry measured the effects of S100A8/S100A9 and YAP on cell proliferation, cell differentiation and apoptosis. Results Here, we report that through activation of the Hippo pathway, suspension and dense culture significantly induce S100A8/S100A9 co-expression and co-localization in SCC cells. Furthermore, these expressional characteristics of S100A8/S100A9 also observed in the xenografts derived from the corresponding SCC cells. Importantly, Co-expression of S100A8/S100A9 detected in 257 SCC specimens derived from five types of SCC tissues. Activation of the Hippo pathway by overexpression of Lats1, knockdown of YAP, as well as disruption of F-actin indeed obviously results in S100A8/S100A9 co-expression in attached SCC cells. Conversely, inhibition of the Hippo pathway leads to S100A8/S100A9 co-expression in a manner opposite of cell suspension and dense. In addition, we found that TEAD1 is required for YAP-induced S100A8/S100A9-expressions. The functional studies provide evidence that knockdown of S100A8/S100A9 together significantly inhibit cell proliferation but promote squamous differentiation and apoptosis. Conclusions Our findings demonstrate for the first time that the expression of S100A8/S100A9 is inducible by changes of cell shape and density through activation of the Hippo pathway in SCC cells. Induced S100A8/S100A9 promoted cell proliferation, inhibit cell differentiation and apoptosis. Electronic supplementary material The online version of this article (10.1186/s12885-019-5784-0) contains supplementary material, which is available to authorized users.
- Subjects :
- 0301 basic medicine
Cancer Research
Squamous Differentiation
Cellular differentiation
Hippo pathway
Cell
Apoptosis
Mice
0302 clinical medicine
Mice, Inbred BALB C
Chemistry
Cell Differentiation
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Cell biology
Proliferation and differentiation
Actin Cytoskeleton
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Carcinoma, Squamous Cell
Heterografts
Female
YAP
Co-expression and co-localization
Research Article
Mice, Nude
Protein Serine-Threonine Kinases
lcsh:RC254-282
03 medical and health sciences
F-actin
S100A8/S100A9
Cell Line, Tumor
Genetics
medicine
Animals
Calgranulin B
Humans
Calgranulin A
Adaptor Proteins, Signal Transducing
Cell Proliferation
Hippo signaling pathway
Cell growth
YAP-Signaling Proteins
Actins
stomatognathic diseases
030104 developmental biology
Cell culture
Cancer cell
Cell apoptosis
Transcription Factors
Subjects
Details
- ISSN :
- 14712407
- Volume :
- 19
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- BMC cancer
- Accession number :
- edsair.doi.dedup.....0a3b09c6d4dc593665e6e1b00874ba8e